Dxcover's Pitch at Growth Unleashed

Last week, on a stage full of innovation inside the historic Mansion House, Dxcover delivered a compelling 8-minute pitch at Growth Unleashed - a landmark event designed to support the Lord Mayor's 2025 vision of economic growth through technology.

Organised by the WCIT Entrepreneurship Panel , this exclusive gathering brought together over 200 senior industry figures who were eager to explore how technology can shape the future and ensure sustainable growth in the UK.

Dxcover: pioneering early cancer diagnosis

At Dxcover, we are making exciting developments in the field of early-stage cancer diagnostics. Our pioneering technology, enabled by infrared spectroscopy and AI, has been specifically developed to identify cancer at an early stage-the point at which treatment is most effective.

Focusing on brain, colorectal cancer, and other solid tumors, we are seeking to transform diagnostics for life-threatening diseases, helping to ultimately speed up pathways for patients to get treatment.

An audience ready to invest in the future

Growth Unleashed provided a perfect stage for Dxcover to showcase our disruptive approach to diagnostics to a room filled with investors, policymakers, and technology leaders. Alongside some of the most promising Healthtech companies in the UK, we underlined in our presentation not only the potential to improve patient outcomes but also the economic impact: reduced strain on healthcare systems and improved access to the diagnostic pathway.

Fuelling the next stage of growth

For companies like Dxcover, exposure to the most influential investors and decision-makers in the City is a very important step on the way to scaling innovation. Whether it's securing funding for further development or forging new partnerships with healthcare providers, Growth Unleashed served as a catalyst for our next phase of expansion. This is in addition to our recent $6.2 million funding boost in total, alongside Macmillan Cancer Support and Maven Capital Partners, bringing the total investment raised by Dxcover to $23.8 million.

In that sense, while the UK is positioning itself as a global leader in MedTech and AI-driven innovation, our pitch stood alongside other cutting-edge tech solutions that work towards not just economic prosperity, but meaningful societal impact. The connections we made during Growth Unleashed will no doubt shape the next chapter of Dxcover's journey - and perhaps that of cancer diagnostics.